[go: up one dir, main page]

MX9300959A - TUMOR NECROSIS FACTOR INHIBITORS. - Google Patents

TUMOR NECROSIS FACTOR INHIBITORS.

Info

Publication number
MX9300959A
MX9300959A MX9300959A MX9300959A MX9300959A MX 9300959 A MX9300959 A MX 9300959A MX 9300959 A MX9300959 A MX 9300959A MX 9300959 A MX9300959 A MX 9300959A MX 9300959 A MX9300959 A MX 9300959A
Authority
MX
Mexico
Prior art keywords
necrosis factor
tumor necrosis
factor inhibitors
inhibitors
tnf
Prior art date
Application number
MX9300959A
Other languages
Spanish (es)
Inventor
Klaus Max Esser
Peter Lawrence Demarsh
Carrie Lynn Frey
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9300959A publication Critical patent/MX9300959A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos que son inhibidores de la producción in vivo de Factor de Necrosis Tumoral (FNT), una proteína de suero.The present invention relates to compounds that are inhibitors of the in vivo production of Tumor Necrosis Factor (TNF), a serum protein.

MX9300959A 1992-02-21 1993-02-22 TUMOR NECROSIS FACTOR INHIBITORS. MX9300959A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83983892A 1992-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
MX9300959A true MX9300959A (en) 1994-08-31

Family

ID=25280753

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300959A MX9300959A (en) 1992-02-21 1993-02-22 TUMOR NECROSIS FACTOR INHIBITORS.

Country Status (4)

Country Link
AU (1) AU3725893A (en)
MX (1) MX9300959A (en)
WO (1) WO1993016699A1 (en)
ZA (1) ZA931222B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
EP1781657B1 (en) * 2004-02-14 2013-03-27 GlaxoSmithKline Intellectual Property Development Limited Medicaments with hm74a receptor activity
RU2395511C2 (en) * 2004-02-14 2010-07-27 Смитклайн Бичам Корпорейшн Novel compounds
WO2007017261A1 (en) 2005-08-10 2007-02-15 Smithkline Beecham Corporation Xanthine derivatives as selective hm74a agonists
BR112017016065A2 (en) * 2015-01-30 2018-04-03 Shanton Pharma Co., Ltd. prevention or treatment of uric acid or gouty disease
WO2023187607A1 (en) 2022-03-29 2023-10-05 Universidade Nova De Lisboa Nickel n-heterocyclic carbene complexes based on xanthines and use therof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds

Also Published As

Publication number Publication date
WO1993016699A1 (en) 1993-09-02
ZA931222B (en) 1993-11-29
AU3725893A (en) 1993-09-13

Similar Documents

Publication Publication Date Title
EA200000449A1 (en) MODIFIED VITAMINS K-DEPENDENT POLYPEPTIDES
ATE184613T1 (en) VARIANTS OF GREEN FLUORESCENCE PROTEIN, GFP
ATE380875T1 (en) CHIMERIC PROTEINS TO AVOID COMPLEMENT ACTIVATION
PT988301E (en) CICID ACIDS OF IMIDAZOLYL
DK0654078T3 (en) Thrombin blood fraction for use in a medical procedure
ATE200677T1 (en) SUBSTITUTED TETRA- AND PENTAPETIDE INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
RU94042393A (en) Galichondrins, related compounds, and method of treating tumor in mammals
EP0715619A4 (en) TUMOR NECROSIS ALPHA FACTOR SECRETION INHIBITORS
ES2134836T3 (en) PROCEDURES FOR THE PRODUCTION OF THROMBIN.
GB9924957D0 (en) Novel treatment
BG101892A (en) Sugar-modified cytostatics
EA199900187A1 (en) LIGAND, RELATED TUMOR NECROSIS FACTOR
BG101038A (en) SURPRISE OF GROWTH OF TUMOR CELLS BY MEDITERRANEAN-1 STUDY
MX9300959A (en) TUMOR NECROSIS FACTOR INHIBITORS.
ES2072490T3 (en) PROCEDURE FOR PASTEURIZATION OF TISSUE PROTEIN PP4.
DE69718469D1 (en) CONNECTIONS WITH GROWTH HORMONE RELEASING PROPERTIES
IL187595A0 (en) Antitumor antibodies, proteins, and uses thereof
ES2146243T3 (en) TNF INHIBITORS.
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
ATE302215T1 (en) MODULATORS OF INTRACELLULAR INFLAMMATORY, CELL DEATH AND CELL SURVIVAL PATHWAYS INCLUDING CARD AND KINASE DOMAIN
EP0663210A3 (en) Inhibitors of tumor necrosis factor production.
SE9803962D0 (en) Nucleic acid encoding a nervous tissue sodium channel
ATE317021T1 (en) ANTISENSE MODULATION OF LFA-3
UA42797C2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives and isoindole derivatives for preparation thereof
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION